Russian translation and validation of SarQoL® – quality of life questionnaire for patients with sarcopenia

Abstract

The aim is to carry out language adaptation and validation on the Russian sample of a special SarQoL questionnaire, designed to assess the quality of life of elderly people with sarcopenia. Material and methods. 100 patients over 65 years, mean age 74.0±6.5 years, observed on an outpatient basis were included. 50 from them had sarcopenia and 50 participants were without it. The diagnosis of sarcopenia was based on criteria developed by the European working group on sarcopenia (EWGSOP, 2010). The validation procedure was carried out in accordance with the Protocol. Results and discussion. There was a significant decrease in the overall quality of life according to SarQoL questionnaire in patients with sarcopenia compared with the control group without sarcopenia (50.65±14.23 and 75.10±14.46, respectively; p<0.001). High internal consistency of the SarQoL (Cronbach's á coefficient 0.924) was revealed. A significant positive correlation of domains with the overall SarQoL index in the range from r=0.37, p=0.0083 to r=0.92, p<0.001 was established. Moderate correlations of SarQoL with some domains SF-36 and the EQ-5D questionnaires were revealed. High internal consistency (ICC) of 0.935 (95% CI 0.91-0.96) was found. Conclusion. The Russian version of the SarQoL questionnaire is valid, consistent and reliable and can be used to assess the quality of life in older patients with sarcopenia.

Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

“…The scoring algorithm is not publicly available, but tools to calculate the scores are available by contacting info@sarqol.org. The clinimetric properties of the questionnaire have been evaluated in 11 different languagespecific versions, and considerable information is available for known-groups validity, construct validity, internal consistency, floor and ceiling effects, test-retest reliability, standard error of measurement, smallest detectable change, and an evaluation of the responsiveness of the SarQoL has also been carried out [9][10][11][12][13][14][15][16][17][18][19][20]. Based on these results, the SarQoL is considered to be a valid, reliable and responsive instrument.…”

“…The clinimetric properties of the SarQoL questionnaire have been examined for 11 language-specific versions of the questionnaire and has demonstrated strong measurement properties [9][10][11][12][13][14][15][16][17][18][19][20]. The questionnaire has been extensively translated, and is available in 30 languages from the website www.…”

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

“…The questionnaire was initially developed and validated in French in 2015 5,6) and was later translated and validated into English, Dutch, Romanian, Polish, Hungarian, Russian, and Greek. [7][8][9][10][11][12][13] To provide the Ukrainian nation with a qualitative and reliable questionnaire to measure the quality of life of sarcopenic patients, we have created the Ukrainian version of the SarQoL questionnaire. The process of translation and validation followed the protocol for translation provided by the authors of the SarQoL questionnaire, which were based on the recommendations of Beaton et al 14) This protocol included translation, cross-cultural adaptation, and validation of psychometric properties of the questionnaire.…”

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL® questionnaire

“…The questionnaire is self‐reported and takes about 15 min to complete. The SarQoL questionnaire has been validated in multiple languages and has been shown to be a valid and reliable instrument 13,15–19,33 . The questionnaire was shown to be responsive to changes in QoL in a sample of 42 sarcopenic subjects followed over 3 years, and its standard error of measurement (SEM) and smallest detectable change have been calculated in different European populations as well as pooled 20,21 …”